zair
ebolaviru
ebov
one
five
speci
ebolavirus
within
filovirida
famili
ebov
continu
caus
signific
outbreak
subsaharan
africa
case
fatal
rate
high
filovirus
broad
speci
cellular
tropism
except
lymphocyt
cell
within
bodi
thought
support
ebov
infect
replic
histopatholog
studi
ebov
infect
human
nonhuman
primat
nhp
demonstr
viral
antigen
mani
differ
organ
includ
liver
spleen
lymph
node
kidney
adren
gland
lung
gastrointestin
tract
skin
brain
heart
numer
cell
surfac
receptor
appreci
mediat
filoviru
bind
intern
endosom
compart
cell
includ
phosphatidylserin
ps
receptor
ctype
lectin
receptor
ps
receptor
interact
viral
glycoprotein
gp
bind
ps
surfac
virion
lipid
membran
caus
intern
viral
particl
endosom
compart
mechan
viral
entri
term
apoptot
mimicri
follow
endosom
uptak
filovirion
proteolyt
gp
process
occur
therebi
allow
gp
interact
endosom
cognat
receptor
niemann
pick
one
import
famili
ps
receptor
tcell
immunoglobulin
mucin
domain
tim
famili
tim
famili
member
encod
havcr
famili
gene
contribut
uptak
apoptot
bodi
clear
die
cell
tissu
circul
tim
protein
type
cell
surfac
glycoprotein
three
famili
member
present
human
four
mice
identifi
bioinformaticsbas
screen
import
filoviru
entri
subsequ
studi
demonstr
enhanc
entri
broad
rang
virus
includ
member
alphaviru
arenaviru
baculoviru
filoviru
flaviviru
famili
murin
also
enhanc
envelop
viru
uptak
endosom
compart
molecular
interact
tim
famili
member
envelop
virus
well
defin
amino
termin
igv
domain
bind
ps
outer
leaflet
viral
membran
igv
domain
bind
pocket
conserv
across
tim
famili
receptor
report
abil
ps
ebola
viru
like
particl
ebov
glycoprotein
pseudotyp
vesicular
stomat
viru
bind
equival
suggest
similar
level
ps
present
surfac
virion
aspart
acid
asparagin
residu
within
igv
bind
pocket
essenti
virion
bind
tim
residu
requir
apoptot
bodi
bind
uptak
igv
domain
extend
plasma
membran
mucin
like
domain
mld
anchor
cell
surfac
transmembran
domain
connect
short
intracellular
cytoplasm
tail
length
specif
sequenc
mld
requir
tim
serv
envelop
viru
receptor
surprisingli
neither
tim
transmembran
domain
cytoplasm
tail
requir
gpianchor
construct
complet
function
viral
receptor
find
indic
cytoplasm
tail
contain
tyrosin
phosphoryl
site
initi
signal
event
essenti
viru
uptak
well
establish
tim
protein
serv
cell
surfac
receptor
number
envelop
virus
infect
cultur
cell
import
famili
member
vivo
filoviru
infect
pathogenesi
extens
examin
wide
varieti
cell
surfac
receptor
abl
mediat
filoviru
uptak
endosom
possibl
suffici
receptor
redund
exist
vivo
loss
one
ps
receptor
may
littl
effect
ebov
viremia
tissu
viru
load
patholog
consequ
altern
specif
cell
surfac
receptor
might
critic
vivo
infect
pathogenesi
ps
receptor
report
mediat
immunomodulatori
proinflammatori
respons
addit
impact
tim
protein
viru
infect
may
due
alter
innat
immun
respons
recent
studi
demonstr
mice
lower
morbid
mortal
wildtyp
mice
challeng
intravascularli
iv
mouseadapt
ebov
maebov
studi
highlight
role
nonpermiss
lymphocyt
report
ebov
interact
cell
enhanc
proinflammatori
cytokin
dysregul
purifi
cell
author
conclud
enhanc
cytokin
storm
cell
significantli
contribut
ebov
pathogenesi
howev
impact
viremia
mice
examin
plasma
singl
time
point
infect
leav
open
possibl
may
also
serv
import
receptor
ebov
entri
vivo
examin
vivo
import
viru
replic
pathogenesi
use
highli
tractabl
model
viru
ebov
viru
model
recombin
vesicular
stomat
viru
vsv
encod
either
full
length
ebov
glycoprotein
mucin
domain
delet
ebov
glycoprotein
place
nativ
vsv
g
protein
ebov
gprvsv
ebov
use
virus
allow
us
conduct
detail
studi
focus
role
viru
entri
host
respons
pathogenesi
report
maebov
observ
ebov
gprvsv
ebov
less
pathogen
mice
compar
mice
impact
loss
specif
ebov
gpexpress
virus
sinc
wildtyp
vsv
equal
virul
mice
wide
rang
challeng
dose
importantli
reduc
mortal
observ
ebov
gp
encod
virusinfect
mice
associ
late
time
infect
lower
viremia
viru
load
multipl
tissu
previous
appreci
import
ebov
pathogenesi
consist
reduc
overal
viru
load
proinflammatori
chemokin
profil
lower
infect
mice
late
time
infect
final
directli
evalu
whether
observ
enhanc
pathogenesi
mice
associ
cell
activ
previous
report
deplet
cell
compart
defici
mice
challeng
ebov
gprvsv
celldeplet
mice
succumb
ebov
gprvsv
readili
celldeplet
mice
suggest
model
system
cell
cytokin
storm
respons
viru
pathogenesi
total
studi
provid
evid
pathogenesi
correl
enhanc
viru
load
late
time
infect
consist
import
role
receptor
ebov
vivo
studi
conduct
strict
accord
anim
welfar
act
recommend
guid
care
use
laboratori
anim
nation
institut
health
univers
iowa
ui
institut
assur
number
anim
procedur
approv
ui
institut
anim
care
use
committe
iacuc
overse
administr
iacuc
protocol
studi
perform
accord
iacuc
guidelin
protocol
filoviru
glycoproteincellular
protein
interact
balbc
mice
previous
describ
kind
gift
dr
paul
rothman
john
hopkin
univers
briefli
exon
gene
replac
lacz
gene
gener
mous
balbc
receptordefici
ifnar
mice
kind
gift
dr
joan
durbin
nyu
langon
medic
center
mice
bred
univers
iowa
balbc
ifnar
balbc
mice
cross
creation
heterozyg
progeni
progeni
interbr
mice
screen
correct
balbc
genotyp
refer
throughout
studi
genom
dna
mous
tailclip
assess
pcr
genotyp
expect
genotyp
produc
normal
mendelian
ratio
primer
protocol
ifnar
genotyp
previous
describ
primer
sequenc
includ
share
forward
gtttgctgccttatttgtgtctgg
wt
revers
cagacatcaactctacaaggtccaagac
knockout
revers
gtctgtcctagcttcctcactg
pcr
amplif
perform
cycl
sec
sec
min
studi
use
recombin
replicationcompet
vesicular
stomat
viru
vsv
express
gfp
either
full
length
ebov
gp
ebov
gprvsvgfp
kind
gift
dr
kartik
chandran
ebov
gp
lack
mucin
domain
ebov
rvsvgfp
encod
nativ
glycoprotein
g
grvsv
kind
gift
dr
sean
whelan
viru
stock
produc
infect
vero
cell
african
green
monkey
kidney
epitheli
cell
line
low
multipl
infect
moi
collect
supernat
hour
follow
infect
viru
stock
concentr
centrifug
rpm
overnight
viru
pellet
resuspend
centrifug
sucros
cushion
ultracentrifug
rpm
hour
beckman
coulter
rotor
pellet
resuspend
pb
treat
endotoxin
remov
agent
thermoscientif
aliquot
frozen
use
five
eightweekold
femal
balbc
ifnar
control
balbc
mice
infect
iv
recombin
infecti
vsv
encod
gfp
ebov
gp
ebov
nativ
vsv
g
glycoprotein
ebov
gprvsvgfp
ebov
grvsvgfp
respect
use
concentr
viru
note
figur
legend
dose
ebov
gprvsv
ebov
administ
depend
upon
stock
dose
stock
titer
vivo
identifi
stock
concentr
gave
predict
high
greater
challeng
mice
level
mortal
ifnar
control
mice
day
studi
grvsvgfp
either
iu
vsv
viru
administ
iv
inject
surviv
track
mice
weigh
score
sick
daili
clinic
assess
sick
score
follow
appar
ill
slightli
ruffl
fur
ruffl
fur
activ
ruffl
fur
inact
ruffl
fur
inact
hunch
postur
moribund
dead
mice
human
euthan
reach
score
mous
infect
studi
conclud
day
follow
infect
due
surviv
mice
regain
lost
weight
sign
clinic
ill
organ
harvest
control
mice
day
follow
infect
ebov
prior
euthanasia
mice
anesthet
isofluran
perform
retroorbit
bleed
serum
mice
euthan
perfus
ml
pb
heart
organ
harvest
weigh
frozen
determin
viru
titer
organ
sera
thaw
organ
homogen
pb
filter
syring
filter
viral
titer
determin
endpoint
dilut
vero
cell
previous
describ
infect
score
day
follow
infect
gfp
posit
use
invert
fluoresc
microscop
viru
titer
calcul
tissu
cultur
infect
dose
ml
spearmankarb
method
organ
titer
normal
accord
weight
organ
harvest
quantit
revers
transcriptas
polymeras
chain
reaction
qrtpcr
use
detect
proinflammatori
cytokin
chemokin
level
organ
mice
challeng
ebov
time
harvest
organ
place
trizol
frozen
use
total
rna
isol
use
trizol
ls
reagent
life
technolog
accord
manufactur
tissu
rna
isol
procedur
rna
quantifi
nanodrop
thermo
scientif
total
rna
revers
transcrib
cdna
use
random
primer
highcapac
cdna
revers
transcript
kit
appli
biosystem
sybr
green
base
quantit
pcr
reaction
appli
biosystem
perform
use
dilut
cdna
reaction
specif
primer
murin
cytokin
chemokin
primer
sequenc
found
tabl
express
level
cytokin
chemokin
interest
defin
ratio
threshold
cycl
ct
valu
gene
interest
endogen
control
mous
hypoxanthin
guanin
phosphoribosyl
transferas
hprt
display
valu
ratio
five
eightweekold
femal
balbc
ifnar
balbc
mice
inject
clone
clone
deplet
monoclon
antibodi
one
day
prior
retroorbit
infect
ebov
gprvsvgfp
two
day
post
infect
surviv
track
mice
weigh
score
sick
daili
describ
assess
euthanasia
criteria
infect
mous
prior
infect
ebov
gprvsvgfp
deplet
valid
isol
peripher
blood
mononuclear
cell
deplet
nondeplet
anim
stain
pbmc
antibodi
clone
stain
done
incub
antibodi
fac
buffer
fc
block
clone
minut
wash
time
remov
excess
antibodi
detect
fluoresc
bd
facscalibur
statist
analys
perform
use
graphpad
prism
softwar
graphpad
softwar
inc
result
shown
mean
geometr
mean
standard
error
mean
sem
geometr
sem
respect
shown
appropri
logrank
mantelcox
test
use
analyz
differ
surviv
vivo
experi
perform
least
duplic
least
mice
total
per
treatment
group
mice
sampl
randomli
assign
variou
treatment
group
data
point
anim
report
result
statist
analys
nonparametr
viral
titer
data
mannwhitney
utest
use
p
valu
less
consid
signific
two
way
comparison
control
experiment
valu
student
ttest
perform
creat
defici
mous
exon
gene
encod
replac
lacz
gene
homolog
recombin
previous
describ
mous
strain
use
studi
role
allerg
airway
diseas
respons
phenotyp
character
mice
reveal
differ
immun
cell
number
immun
system
develop
immunolog
homeostasi
compar
wt
mice
balbc
mice
bred
onto
balbc
interferon
receptor
ifnar
knock
background
sinc
type
interferon
abrog
replic
recombin
ebov
gprvsv
use
studi
homozyg
balbc
ifnar
mice
call
control
mice
respect
throughout
remaind
studi
use
infect
challeng
viru
administ
intraven
mimic
primari
rout
ebov
transmiss
bloodtoblood
contact
mice
challeng
lowest
dose
viru
produc
predict
death
control
mice
day
fig
minor
titer
variat
observ
viru
stock
dosag
adjust
accordingli
challeng
control
mice
full
length
ebov
gprvsv
ebov
mucin
like
domain
mld
delet
ebov
pseudovirion
recombin
virus
tropism
viru
bear
ebov
gp
use
virus
studi
allow
us
determin
elimin
mucin
domain
alter
pathogenesi
associ
vivo
challeng
virus
expect
control
mice
succumb
ebov
gprvsv
ebov
day
infect
fig
contrast
mice
challeng
dose
significantli
reduc
mortal
follow
ebov
gprvsv
ebov
infect
delay
timetodeath
succumb
infect
find
indic
mice
improv
surviv
infect
ebov
gprvsv
compar
control
surviv
affect
presenc
mld
tissu
cultur
studi
shown
mediat
wt
vsv
entri
presum
cognat
receptor
vsv
ldl
receptor
abundantli
present
target
cell
mediat
vsv
entri
howev
relev
vivo
vsv
infect
examin
wt
vsv
serv
excel
control
vivo
studi
ebov
gpbear
virus
challeng
control
mice
iu
vsv
iv
inject
contrast
ebov
gprvsv
find
observ
differ
surviv
curv
two
strain
mice
fig
sinc
like
vsv
bear
nativ
gp
pathogen
recombin
vsv
contain
differ
viral
gp
also
evalu
mortal
associ
differ
dose
vsv
found
administr
littl
iu
vsv
lethal
ifnar
mice
fig
thu
repeat
vsv
infect
control
mice
challeng
dose
iu
determin
subtl
chang
viru
pathogenesi
could
discern
even
low
dose
differ
surviv
mice
versu
control
mice
fig
result
provid
evid
differ
ebov
gprvsv
pathogenesi
balbc
ifnar
mice
due
presenc
ebov
gp
express
recombin
vsv
rather
vsv
gene
reduc
pathogenesi
ebov
gp
express
viru
mice
consist
find
describ
younan
et
al
use
maebov
effect
express
viremia
organ
viral
load
follow
iv
ebov
infect
examin
serum
organ
harvest
day
follow
infect
fig
viremia
infecti
viru
variou
organ
quantifi
endpoint
dilut
titer
vero
cell
highli
permiss
cell
line
ebov
earli
time
infect
differ
viremia
viru
load
observ
organ
versu
control
mice
howev
day
ebov
infect
mice
reduct
viremia
compar
control
mice
fig
similar
trend
observ
infect
full
length
ebov
gprvsv
fig
parallel
level
infecti
viru
liver
kidney
adren
gland
also
significantli
reduc
studi
day
infect
also
indic
ebov
load
much
reduc
brain
mice
trend
lower
testi
fig
consist
overal
reduct
viru
load
mice
late
time
infect
thu
reduc
viru
replic
number
organ
associ
surviv
observ
mice
find
provid
evid
express
import
gener
high
viral
load
organ
late
time
infect
viral
load
spleen
lung
affect
loss
fig
fig
viral
burden
spleen
significantli
higher
day
organ
assess
remain
high
mous
strain
throughout
cours
infect
peak
titer
occur
day
result
consist
previou
studi
implic
spleen
earli
sustain
ebov
replic
lung
titer
significantli
differ
control
mice
day
follow
infect
result
somewhat
unexpect
previous
demonstr
robust
express
apic
surfac
airway
epitheli
cell
observ
express
basolater
side
lung
epithelium
may
import
entri
aerosol
ebov
entri
host
may
influenc
basolater
infect
lung
via
circul
elev
proinflammatori
immunomodulatori
cytokin
chemokin
evid
serum
infect
organ
ebov
infect
anim
model
patient
determin
reduc
viru
load
mice
late
time
point
associ
lower
rna
express
profil
select
wellcharacter
cytokin
level
spleen
liver
kidney
examin
prior
follow
ebov
infect
organ
harvest
day
infect
total
rna
isol
amplifi
mrna
housekeep
gene
hprt
cytokin
tnf
cytokin
express
level
normal
mous
hprt
express
overal
baselin
valu
organ
cytokin
express
uninfect
control
mice
similar
fig
day
infect
tnf
significantli
higher
spleen
control
mice
gener
infect
express
cytokin
variabl
within
group
level
significantli
differ
two
strain
mice
elev
level
sever
chemokin
growth
factor
implic
fatal
ebov
diseas
outcom
includ
mcsf
mif
eotaxin
therefor
analyz
control
organ
follow
ebov
infect
chemokin
least
one
two
transcript
proinflammatori
chemokin
three
organ
elev
control
mice
day
andor
infect
compar
mous
tissu
fig
combin
surviv
viral
burden
result
observ
suggest
presenc
mice
contribut
ebov
gprvsv
pathogenesi
increas
infect
cell
sever
organ
late
time
infect
associ
increas
express
proinflammatori
chemokin
express
number
differ
hematopoiet
nonhematopoiet
cell
find
indic
viru
load
spleen
organ
rich
hematopoiet
cell
affect
loss
express
suggest
might
express
nonhematopoiet
cell
late
infect
affect
ebov
gprvsv
load
surviv
other
suggest
cell
subset
contribut
enhanc
ebov
pathogenesi
deplet
cell
control
mice
assess
outcom
ebov
gprvsv
infect
mice
intraperiton
administ
mab
mab
day
verifi
cell
within
peripher
blood
profoundli
deplet
day
infect
flow
cytometri
follow
immunostain
mab
fig
observ
cellcompet
mice
studi
celldeplet
control
mice
challeng
ebov
gprvsv
succumb
infect
day
wherea
celldeplet
mice
significantli
better
surviv
fig
data
provid
support
content
cell
contribut
pathogenesi
associ
viral
infect
model
instead
total
find
consist
express
nont
cell
popul
contribut
pathogenesi
show
loss
express
decreas
overal
mortal
delay
timetodeath
mice
succumb
challeng
ebov
gprvsv
impact
surviv
express
similar
rvsv
bear
mlddelet
ebov
gp
indic
presenc
mld
affect
observ
pathogenesi
consist
enhanc
surviv
mice
follow
viru
challeng
show
mice
also
reduc
infecti
viru
liver
kidney
adren
gland
late
time
infect
ebov
replic
organ
well
establish
thought
contribut
overal
ebov
load
lower
viru
load
organ
mice
also
reflect
reduct
viremia
day
infect
reduc
patholog
mice
ebov
gpdepend
sinc
surviv
associ
grvsv
infect
unaffect
express
thu
studi
indic
glycoprotein
present
virion
respons
chang
viru
load
mous
surviv
correl
enhanc
surviv
reduc
viral
load
mice
suggest
serv
viru
receptor
ebov
organ
howev
role
must
late
infect
sinc
viremia
organ
viru
load
differ
two
mous
strain
day
infect
number
studi
shown
earli
time
infect
ebov
antigen
primarili
exclus
found
cell
myeloid
compart
cell
express
howev
infect
progress
addit
cell
type
becom
ebov
antigen
posit
suggest
spread
viru
cell
type
data
suggest
later
group
cell
contribut
viru
infect
pathogenesi
like
late
cell
target
express
would
includ
kidney
epitheli
cell
epitheli
popul
adren
gland
eye
liver
brain
testi
interestingli
observ
organ
previous
implic
import
ebov
infect
lower
viru
load
mice
splenic
viral
load
high
throughout
infect
control
mice
data
suggest
express
cell
appreci
contribut
splenic
viru
load
splenic
load
high
mice
without
anim
necessarili
succumb
infect
interact
directli
ebov
gp
bind
virionassoci
ps
shown
elicit
viral
particl
entri
endosom
compart
ebov
gp
proteolyt
process
bind
mediat
membran
fusion
filovir
particl
entri
endosom
occur
interact
number
cell
surfac
receptor
tissu
cultur
howev
studi
younan
et
al
provid
support
import
vivo
infect
contribut
ebov
pathogenesi
futur
studi
evalu
role
addit
cell
surfac
receptor
implic
ebov
entri
would
provid
valuabl
insight
potenti
receptor
redund
receptor
includ
tim
famili
member
tam
tyrosin
kinas
receptor
ctype
lectin
studi
perform
younan
et
al
deliv
ebov
gprvsv
intraven
studi
observ
intraperiton
ip
deliveri
ebov
gprvsv
maebov
wt
versu
mice
equal
pathogen
find
may
explain
previou
observ
anoth
tim
famili
member
highli
express
resid
periton
macrophag
use
receptor
ebov
like
use
receptor
within
compart
usurp
need
express
ip
challeng
even
late
infect
surprisingli
younan
et
al
observ
mice
decreas
maebov
virema
author
report
genom
copi
number
plasma
significantli
differ
defici
mice
day
infect
discrep
find
previou
studi
may
due
tissu
examin
viru
administ
quantiti
viru
administ
andor
time
sampl
one
notabl
differ
studi
younan
et
al
administ
larg
dose
maebov
mice
wherea
dose
viru
given
mice
studi
minim
lethal
dose
determin
preliminari
titrat
studi
physiolog
role
extens
studi
agonist
monoclon
antibodi
bind
inkt
splenic
b
cell
induc
cellular
activ
wide
rang
organ
zebrafish
human
observ
led
understand
serv
costimulatori
molecul
cell
lead
upregul
cytokin
nkt
cell
well
antibodi
product
b
cell
contrast
transient
express
injur
kidney
epitheli
cell
serv
antiinflammatori
role
uptak
clearanc
apoptot
bodi
younan
et
al
describ
role
ebov
patholog
stimul
cell
cytokin
chemokin
dysregul
gener
observ
signific
differ
proinflammatori
cytokin
mice
even
late
time
infect
titer
differ
notabl
certainli
possibl
cytokin
evalu
might
dramat
alter
observ
elev
level
proinflammatori
chemokin
transcript
mice
compar
defici
mice
postul
higher
level
chemokin
mice
may
reflect
innat
immun
respons
stimul
higher
viru
load
altern
postul
younan
et
al
elev
chemokin
profil
associ
mortal
mice
might
due
cytokin
storm
elicit
cell
test
latter
possibl
viru
challeng
celldeplet
mice
cell
deplet
alter
ebov
gprvsv
patholog
found
significantli
greater
mortal
associ
viru
infect
mice
deplet
cell
celldeplet
mice
suggest
cell
respons
reduc
surviv
mice
henc
find
support
conclus
express
cell
play
signific
role
patholog
associ
acut
infect
caveat
studi
infect
perform
mice
ifnar
background
possibl
level
cytokin
chemokin
observ
studi
influenc
genet
background
mice
other
look
effect
ifnar
background
immun
respons
studi
shown
number
cytokin
chemokin
suppress
absenc
type
interferon
ifn
respons
first
hour
viru
infect
howev
hour
viral
infect
burst
product
transcript
protein
wildtyp
mice
report
subsid
level
wildtyp
ifnar
anim
roughli
equival
studi
investig
cytokin
chemokin
level
later
point
day
infect
direct
impact
lack
type
ifn
may
minim
furthermor
cytokin
chemokin
suppress
ifnar
mice
express
protein
enhanc
ablat
signal
pathway
addit
wildtyp
ebov
infect
note
ebov
type
ifn
antagonist
also
rapidli
suppress
type
ifn
pathway
thu
ebov
gprvsv
studi
ifnar
mice
may
recapitul
number
aspect
immun
suppress
elicit
wildtyp
filovirus
result
also
demonstr
import
wt
vsv
pathogenesi
due
wide
cellular
tropism
vsv
ubiquit
cell
lipid
compon
ps
phosphatidylinositol
gangliosid
origin
propos
vsv
cell
surfac
receptor
howev
recent
investig
reveal
lipid
readili
use
vsv
cell
surfac
receptor
instead
ldl
receptor
famili
member
propos
serv
vsv
receptor
human
mous
cell
therefor
vivo
pathogenesi
induc
vsv
would
differ
ebov
gprvsv
sinc
depend
ldl
receptor
entri
confer
vsv
g
glycoprotein
presum
vsv
membran
contain
ps
interact
affin
vsv
g
ldl
receptor
like
greater
affin
ps
virion
envelop
toward
ps
receptor
like
studi
lab
shown
high
affin
interact
lassa
viru
gp
receptor
abrog
mediat
lassa
viru
pseudovirion
entri
futur
studi
would
valuabl
assess
abil
vsv
util
cell
surfac
receptor
absenc
express
ldl
receptor
second
explan
lack
wt
vsv
util
ps
receptor
mutual
exclus
first
quantiti
vsv
g
versu
ebov
glycoprotein
incorpor
onto
surfac
vsv
may
greater
explor
directli
date
fewer
ebov
glycoprotein
present
virion
abil
virion
associ
ps
interact
ps
receptor
might
increas
liver
kidney
dysfunct
necrosi
integr
aspect
ebov
patholog
human
nhp
mice
studi
indic
express
associ
elev
viral
load
liver
kidney
adren
gland
brain
sinc
loss
significantli
lower
viral
burden
organ
futur
studi
need
explor
impact
express
ebov
infect
specif
cell
within
organ
identifi
express
cell
serv
viral
target
understand
contribut
cell
ebov
diseas
pathogenesi
abl
better
develop
specif
therapeut
ebov
infect
